

The global Fertility Preservation Service market size is predicted to grow from US$ 76.9 million in 2025 to US$ 109 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
United States market for Fertility Preservation Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Fertility Preservation Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Fertility Preservation Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Fertility Preservation Service players cover Kaiser Permanente, Johns Hopkins Medicine, ReproTech, California Cryobank, Guy's and St Thomas' Private Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淔ertility Preservation Service Industry Forecast鈥 looks at past sales and reviews total world Fertility Preservation Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Fertility Preservation Service sales for 2025 through 2031. With Fertility Preservation Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fertility Preservation Service industry.
This Insight Report provides a comprehensive analysis of the global Fertility Preservation Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Fertility Preservation Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global Fertility Preservation Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fertility Preservation Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fertility Preservation Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Fertility Preservation Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Egg Freezing
Embryo Freezing
Ovarian Translocation
Sperm Freezing
Others
Segmentation by Application:
Female
Male
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Kaiser Permanente
Johns Hopkins Medicine
ReproTech
California Cryobank
Guy's and St Thomas' Private Healthcare
Sutter Health
Penn Medicine
Weill Medical College
Cook Children's Health Care System
Pacific Centre for Reproductive Medicine
Seattle Reproductive Medicine
Manchester Fertility
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Fertility Preservation Service 麻豆原创 Size (2020-2031)
2.1.2 Fertility Preservation Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Fertility Preservation Service by Country/Region (2020, 2024 & 2031)
2.2 Fertility Preservation Service Segment by Type
2.2.1 Egg Freezing
2.2.2 Embryo Freezing
2.2.3 Ovarian Translocation
2.2.4 Sperm Freezing
2.2.5 Others
2.3 Fertility Preservation Service 麻豆原创 Size by Type
2.3.1 Fertility Preservation Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Fertility Preservation Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Fertility Preservation Service Segment by Application
2.4.1 Female
2.4.2 Male
2.5 Fertility Preservation Service 麻豆原创 Size by Application
2.5.1 Fertility Preservation Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Fertility Preservation Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Fertility Preservation Service 麻豆原创 Size by Player
3.1 Fertility Preservation Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Fertility Preservation Service Revenue by Player (2020-2025)
3.1.2 Global Fertility Preservation Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Fertility Preservation Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Fertility Preservation Service by Region
4.1 Fertility Preservation Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Fertility Preservation Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Fertility Preservation Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Fertility Preservation Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Fertility Preservation Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Fertility Preservation Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Fertility Preservation Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Fertility Preservation Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Fertility Preservation Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fertility Preservation Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Fertility Preservation Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Fertility Preservation Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Fertility Preservation Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Fertility Preservation Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Fertility Preservation Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fertility Preservation Service by Region (2020-2025)
8.2 Middle East & Africa Fertility Preservation Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Fertility Preservation Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Fertility Preservation Service 麻豆原创 Forecast
10.1 Global Fertility Preservation Service Forecast by Region (2026-2031)
10.1.1 Global Fertility Preservation Service Forecast by Region (2026-2031)
10.1.2 Americas Fertility Preservation Service Forecast
10.1.3 APAC Fertility Preservation Service Forecast
10.1.4 Europe Fertility Preservation Service Forecast
10.1.5 Middle East & Africa Fertility Preservation Service Forecast
10.2 Americas Fertility Preservation Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Fertility Preservation Service Forecast
10.2.2 Canada 麻豆原创 Fertility Preservation Service Forecast
10.2.3 Mexico 麻豆原创 Fertility Preservation Service Forecast
10.2.4 Brazil 麻豆原创 Fertility Preservation Service Forecast
10.3 APAC Fertility Preservation Service Forecast by Region (2026-2031)
10.3.1 China Fertility Preservation Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Fertility Preservation Service Forecast
10.3.3 Korea 麻豆原创 Fertility Preservation Service Forecast
10.3.4 Southeast Asia 麻豆原创 Fertility Preservation Service Forecast
10.3.5 India 麻豆原创 Fertility Preservation Service Forecast
10.3.6 Australia 麻豆原创 Fertility Preservation Service Forecast
10.4 Europe Fertility Preservation Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Fertility Preservation Service Forecast
10.4.2 France 麻豆原创 Fertility Preservation Service Forecast
10.4.3 UK 麻豆原创 Fertility Preservation Service Forecast
10.4.4 Italy 麻豆原创 Fertility Preservation Service Forecast
10.4.5 Russia 麻豆原创 Fertility Preservation Service Forecast
10.5 Middle East & Africa Fertility Preservation Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Fertility Preservation Service Forecast
10.5.2 South Africa 麻豆原创 Fertility Preservation Service Forecast
10.5.3 Israel 麻豆原创 Fertility Preservation Service Forecast
10.5.4 Turkey 麻豆原创 Fertility Preservation Service Forecast
10.6 Global Fertility Preservation Service Forecast by Type (2026-2031)
10.7 Global Fertility Preservation Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Fertility Preservation Service Forecast
11 Key Players Analysis
11.1 Kaiser Permanente
11.1.1 Kaiser Permanente Company Information
11.1.2 Kaiser Permanente Fertility Preservation Service Product Offered
11.1.3 Kaiser Permanente Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Kaiser Permanente Main Business Overview
11.1.5 Kaiser Permanente Latest Developments
11.2 Johns Hopkins Medicine
11.2.1 Johns Hopkins Medicine Company Information
11.2.2 Johns Hopkins Medicine Fertility Preservation Service Product Offered
11.2.3 Johns Hopkins Medicine Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Johns Hopkins Medicine Main Business Overview
11.2.5 Johns Hopkins Medicine Latest Developments
11.3 ReproTech
11.3.1 ReproTech Company Information
11.3.2 ReproTech Fertility Preservation Service Product Offered
11.3.3 ReproTech Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 ReproTech Main Business Overview
11.3.5 ReproTech Latest Developments
11.4 California Cryobank
11.4.1 California Cryobank Company Information
11.4.2 California Cryobank Fertility Preservation Service Product Offered
11.4.3 California Cryobank Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 California Cryobank Main Business Overview
11.4.5 California Cryobank Latest Developments
11.5 Guy's and St Thomas' Private Healthcare
11.5.1 Guy's and St Thomas' Private Healthcare Company Information
11.5.2 Guy's and St Thomas' Private Healthcare Fertility Preservation Service Product Offered
11.5.3 Guy's and St Thomas' Private Healthcare Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Guy's and St Thomas' Private Healthcare Main Business Overview
11.5.5 Guy's and St Thomas' Private Healthcare Latest Developments
11.6 Sutter Health
11.6.1 Sutter Health Company Information
11.6.2 Sutter Health Fertility Preservation Service Product Offered
11.6.3 Sutter Health Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Sutter Health Main Business Overview
11.6.5 Sutter Health Latest Developments
11.7 Penn Medicine
11.7.1 Penn Medicine Company Information
11.7.2 Penn Medicine Fertility Preservation Service Product Offered
11.7.3 Penn Medicine Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Penn Medicine Main Business Overview
11.7.5 Penn Medicine Latest Developments
11.8 Weill Medical College
11.8.1 Weill Medical College Company Information
11.8.2 Weill Medical College Fertility Preservation Service Product Offered
11.8.3 Weill Medical College Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Weill Medical College Main Business Overview
11.8.5 Weill Medical College Latest Developments
11.9 Cook Children's Health Care System
11.9.1 Cook Children's Health Care System Company Information
11.9.2 Cook Children's Health Care System Fertility Preservation Service Product Offered
11.9.3 Cook Children's Health Care System Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Cook Children's Health Care System Main Business Overview
11.9.5 Cook Children's Health Care System Latest Developments
11.10 Pacific Centre for Reproductive Medicine
11.10.1 Pacific Centre for Reproductive Medicine Company Information
11.10.2 Pacific Centre for Reproductive Medicine Fertility Preservation Service Product Offered
11.10.3 Pacific Centre for Reproductive Medicine Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Pacific Centre for Reproductive Medicine Main Business Overview
11.10.5 Pacific Centre for Reproductive Medicine Latest Developments
11.11 Seattle Reproductive Medicine
11.11.1 Seattle Reproductive Medicine Company Information
11.11.2 Seattle Reproductive Medicine Fertility Preservation Service Product Offered
11.11.3 Seattle Reproductive Medicine Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Seattle Reproductive Medicine Main Business Overview
11.11.5 Seattle Reproductive Medicine Latest Developments
11.12 Manchester Fertility
11.12.1 Manchester Fertility Company Information
11.12.2 Manchester Fertility Fertility Preservation Service Product Offered
11.12.3 Manchester Fertility Fertility Preservation Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Manchester Fertility Main Business Overview
11.12.5 Manchester Fertility Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.